Pharmacovigilance Market by Type (Spontaneous Reporting), Service Provider (In-house), by Product Life Cycle (Preclinical), Therapeutic Area (Cardiology), by Process Flow (Signal Detection), End Use (Pharmaceuticals) and by Region - Global Forecast to 2022-2033

The pharmacovigilance market size is estimated to be USD 6,590.8 million in 2022 and is expected to witness a CAGR of 11.84% during the forecast period 2023-2033. The rising quantity of ADRs and associated consumer hazards, the growing elderly population, and increased usage of drugs globally as chronic illnesses including diabetes, cardiovascular, oncological, and respiratory ailments are factors contributing to the market growth. However, internet-based medicine information and the lack of available competent personnel are expected to hinder the growth.

Segmentation

By Type

On the basis of type, the market is categorized into intensified ADR reporting, spontaneous reporting, EHR mining, cohort event monitoring, and targeted spontaneous reporting. In the global market, the targeted spontaneous reporting segment accounted for the largest revenue share in 2022 owing to the widely used technique for the quick and low-cost identification of novel, severe, and uncommon ADRs.

By Service Provider

Based on service provider, the market is categorized into contract outsourcing and in-house. In 2022, the contract outsourcing accounted for the highest revenue share due to the advantages of outsourcing, such as risk reduction, resource flexibility, a decrease in initial outlays, and a decline in fixed expenses.

By Product Life Cycle

On the basis of product life cycle, the market is categorized into phase 1, phase 2, phase 3, phase 4, and preclinical. In the global market, the segment accounted for the largest revenue share in 2022 owing to the extensive drug testing on a large patient base, the data gathered and evaluated during this stage.

By Therapeutic Area

Based on therapeutic area, the market is categorized into cardiology, oncology, respiratory systems, neurology, and others. In 2022, the oncology accounted for the highest revenue share due to the rising incidence of cancer.

By Process Flow

Based on process flow, the market is segmented into signal detection, risk management system, and case data management. In 2022, the signal detection segment accounted for the largest revenue share owing to spontaneous reporting systems (SRSs) rely on the primary signal source via which healthcare professionals voluntarily report suspicious cases to other regulatory agencies.

By End Use

In terms of end use, the market is divided into medical device manufacturers, pharmaceuticals, biotechnology companies, and others. In the global market, the pharmaceuticals segment accounted for the largest revenue share in 2022 owing to the fact that the pharma companies outsource the pharmacovigilance process to reduce high upfront costs and fixed operational costs, improve resource flexibility, and obtain extra capacity.

Regional Markets

North America held the largest revenue share in the pharmacovigilance market in 2022, and it is predicted to continue to do so throughout the forecast period. This is attributed to growing spending by key stakeholders on the development of innovative drugs, the growing rate of drug addiction and adverse drug responses is a primary cause of illness and mortality, and the existence of major manufacturers of pharmaceuticals and medical equipment. However, the Asia-Pacific region is predicted to grow at the fastest rate during the projection period owing to the increasing investments and encouraging government programs to satisfy the needs of the populace, rising patient consciousness, the accessibility of different outsourcing companies, and increased output, reduced costs, and sharing of resources.

Competitor Insights

Some of the key players operating in the pharmacovigilance market are Accenture (Ireland), ArisGlobal (US), Capgemini (France), Cognizant (US), FMD K&L (US), IBM Corporation (US), ICON plc. (Ireland), IQVIA (US), ITClinical (Portugal), Laboratory Corporation of America Holdings (US), Linical Accelovance (US), PAREXEL International Corporation (US), TAKE Solutions Ltd. (India), and Wipro Ltd. (India).

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including type, service provider, product life cycle, therapeutic area, process flow, and end use from 2023 to 2033.

Report Scope:

Key Parameters Details
Market size in 2022
  • USD 6,590.8 Million
CAGR
  • 11.84%
Base Year
  • 2022
Forecast Period
  • 2023-2033
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • COVID-19 impact analysis
Segment Market Scope
  • Type
  • Service Provider
  • Product Life Cycle
  • Therapeutic Area
  • Process Flow
  • End use
Regional Market Scope
  • North America
    (U.S. and Canada)
  • Europe
    (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific
    (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America
    (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA
    (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 10 players
  • Other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Segmentation: Pharmacovigilance Market Report 2022 – 2033

Type (Revenue, USD Million), 2022 – 2033

  • Intensified ADR Reporting
  • Spontaneous Reporting
  • EHR Mining
  • Cohort Event Monitoring
  • Targeted Spontaneous Reporting

Service Provider (Revenue, USD Million), 2022 – 2033

  • Contract Outsourcing
  • In-house

Product Life Cycle (Revenue, USD Million), 2022 – 2033

  • Preclinical
  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4

Therapeutic Area (Revenue, USD Million), 2022 – 2033

  • Cardiology
  • Oncology
  • Respiratory Systems
  • Neurology
  • Others

Process Flow (Revenue, USD Million), 2022 – 2033

  • Signal Detection
  • Risk Management System
  • Case Data Management

End user (Revenue, USD Million), 2022 – 2033

  • Medical Device Manufacturers
  • Pharmaceuticals
  • Biotechnology Companies
  • Others

By Region (Revenue, USD Million), 2022 – 2033

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Table of Contents: Pharmacovigilance Market 2022-2033

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
  1. Introduction: Pharmacovigilance
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis: Pharmacovigilance Market  
  3. Market Analysis by Type
    1. Intensified ADR Reporting
      1. Intensified ADR Reporting Market Forecast, 2022-2033 (USD Million)
    2. Spontaneous Reporting
      1. Spontaneous Reporting Market Forecast, 2022-2033 (USD Million)
    3. EHR Mining
      1. EHR Mining Market Forecast, 2022-2033 (USD Million)
    4. Cohort Event Monitoring
      1. Cohort Event Monitoring Market Forecast, 2022-2033 (USD Million)
    5. Targeted Spontaneous Reporting
      1. Targeted Spontaneous Reporting Market Forecast, 2022-2033 (USD Million)
  1. Market Analysis by Service Provider
    1. Contract Outsourcing
      1. Contract Outsourcing Market Forecast, 2022-2033 (USD Million)
    2. In-house
      1. In-house Market Forecast, 2022-2033 (USD Million)
  1. Market Analysis by Product Life Cycle
    1. Preclinical
      1. Preclinical Market Forecast, 2022-2033 (USD Million)
    2. Phase 1
      1. Phase 1 Market Forecast, 2022-2033 (USD Million)
    3. Phase 2
      1. Phase 2 Market Forecast, 2022-2033 (USD Million)
    4. Phase 3
      1. Phase 3 Market Forecast, 2022-2033 (USD Million)
    5. Phase 4
      1. Phase 4 Market Forecast, 2022-2033 (USD Million)
  1. Market Analysis by Therapeutic Area
    1. Cardiology
      1. Cardiology Market Forecast, 2022-2033 (USD Million)
    2. Oncology
      1. Oncology Market Forecast, 2022-2033 (USD Million)
    3. Respiratory Systems
      1. Respiratory Systems Market Forecast, 2022-2033 (USD Million)
    4. Neurology
      1. Neurology Market Forecast, 2022-2033 (USD Million)
    5. Others
      1. Others Market Forecast, 2022-2033 (USD Million)
  1. Market Analysis by Process Flow
    1. Signal Detection
      1. Signal Detection Market Forecast, 2022-2033 (USD Million)
    2. Risk Management System
      1. Risk Management System Market Forecast, 2022-2033 (USD Million)
    3. Case Data Management
      1. Case Data Management Market Forecast, 2022-2033 (USD Million)
  1. Market Analysis by End Use
    1. Medical Device Manufacturers
      1. Medical Device Manufacturers Market Forecast, 2022-2033 (USD Million)
    2. Pharmaceuticals
      1. Pharmaceuticals Market Forecast, 2022-2033 (USD Million)
    3. Biotechnology Companies
      1. Biotechnology Companies Market Forecast, 2022-2033 (USD Million)
    4. Others
      1. Others Market Forecast, 2022-2033 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
  2. North America Pharmacovigilance Market  
    1. North America Pharmacovigilance Market
      1. North America Market Size and Forecast, 2022-2033 (USD Million)
        1. Market Size and Forecast by Type, 2022-2033 (USD Million)
        2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
        3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
        4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
        5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
        6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
      2. S. Pharmacovigilance Market
        1. S. Market Size and Forecast, 2022-2033 (USD Million)
          1. Market Size and Forecast by Type, 2022-2033 (USD Million)
          2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
          3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
          4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
          5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
          6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
        2. Canada Pharmacovigilance Market
          1. Canada Market Size and Forecast, 2022-2033 (USD Million)
            1. Market Size and Forecast by Type, 2022-2033 (USD Million)
            2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
            3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
            4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
            5. Market Size and Forecast by Process Flow, 2022-2033 (USD Million)
            6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
  1. Europe Pharmacovigilance Market  
    1. Europe Pharmacovigilance Market
      1. Europe Market Size and Forecast, 2022-2033 (USD Million)
        1. Market Size and Forecast by Type, 2022-2033 (USD Million)
        2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
        3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
        4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
        5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
        6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
      2. Germany Pharmacovigilance Market
        1. Germany Market Size and Forecast, 2022-2033 (USD Million)
          1. Market Size and Forecast by Type, 2022-2033 (USD Million)
          2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
          3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
          4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
          5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
          6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
        2. UK Pharmacovigilance Market
          1. UK Market Size and Forecast, 2022-2033 (USD Million)
            1. Market Size and Forecast by Type, 2022-2033 (USD Million)
            2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
            3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
            4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
            5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
            6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
          2. France Pharmacovigilance Market
            1. France Market Size and Forecast, 2022-2033 (USD Million)
              1. Market Size and Forecast by Type, 2022-2033 (USD Million)
              2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
              3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
              4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
              5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
              6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
            2. Spain Pharmacovigilance Market
              1. Spain Market Size and Forecast, 2022-2033 (USD Million)
                1. Market Size and Forecast by Type, 2022-2033 (USD Million)
                2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
                3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
                4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
                5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
                6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
              2. Italy Pharmacovigilance Market
                1. Italy Market Size and Forecast, 2022-2033 (USD Million)
                  1. Market Size and Forecast by Type, 2022-2033 (USD Million)
                  2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
                  3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
                  4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
                  5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
                  6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
                2. Rest of Europe Pharmacovigilance Market
                  1. Rest of Europe Market Size and Forecast, 2022-2033 (USD Million)
                    1. Market Size and Forecast by Type, 2022-2033 (USD Million)
                    2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
                    3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
                    4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
                    5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
                    6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
  1. Asia Pacific Pharmacovigilance Market  
    1. Asia Pacific Pharmacovigilance Market
      1. Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
        1. Market Size and Forecast by Type, 2022-2033 (USD Million)
        2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
        3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
        4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
        5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
        6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
      2. Japan Pharmacovigilance Market
        1. Japan Market Size and Forecast, 2022-2033 (USD Million)
          1. Market Size and Forecast by Type, 2022-2033 (USD Million)
          2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
          3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
          4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
          5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
          6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
        2. China Pharmacovigilance Market
          1. China Market Size and Forecast, 2022-2033 (USD Million)
            1. Market Size and Forecast by Type, 2022-2033 (USD Million)
            2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
            3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
            4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
            5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
            6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
          2. India Pharmacovigilance Market
            1. India Market Size and Forecast, 2022-2033 (USD Million)
              1. Market Size and Forecast by Type, 2022-2033 (USD Million)
              2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
              3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
              4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
              5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
              6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
            2. South Korea Pharmacovigilance Market
              1. South Korea Market Size and Forecast, 2022-2033 (USD Million)
                1. Market Size and Forecast by Type, 2022-2033 (USD Million)
                2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
                3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
                4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
                5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
                6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
              2. Australia Pharmacovigilance Market
                1. Australia Market Size and Forecast, 2022-2033 (USD Million)
                  1. Market Size and Forecast by Type, 2022-2033 (USD Million)
                  2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
                  3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
                  4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
                  5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
                  6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
                2. Rest of Asia Pacific Pharmacovigilance Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
                    1. Market Size and Forecast by Type, 2022-2033 (USD Million)
                    2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
                    3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
                    4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
                    5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
                    6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
  1. Latin America Pharmacovigilance Market  
    1. Latin America Pharmacovigilance Market
      1. Latin America Market Size and Forecast, 2022-2033 (USD Million)
        1. Market Size and Forecast by Type, 2022-2033 (USD Million)
        2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
        3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
        4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
        5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
        6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
      2. Brazil Pharmacovigilance Market
        1. Brazil Market Size and Forecast, 2022-2033 (USD Million)
          1. Market Size and Forecast by Type, 2022-2033 (USD Million)
          2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
          3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
          4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
          5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
          6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
        2. Mexico Pharmacovigilance Market
          1. Mexico Market Size and Forecast, 2022-2033 (USD Million)
            1. Market Size and Forecast by Type, 2022-2033 (USD Million)
            2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
            3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
            4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
            5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
            6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
          2. Argentina Pharmacovigilance Market
            1. Argentina Market Size and Forecast, 2022-2033 (USD Million)
              1. Market Size and Forecast by Type, 2022-2033 (USD Million)
              2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
              3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
              4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
              5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
              6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
            2. Rest of Latin America Pharmacovigilance Market
              1. Rest of Latin America Market Size and Forecast, 2022-2033 (USD Million)
                1. Market Size and Forecast by Type, 2022-2033 (USD Million)
                2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
                3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
                4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
                5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
                6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)

 

  1. MEA Pharmacovigilance Market  
    1. MEA Pharmacovigilance Market
      1. MEA Market Size and Forecast, 2022-2033 (USD Million)
        1. Market Size and Forecast by Type, 2022-2033 (USD Million)
        2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
        3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
        4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
        5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
        6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
      2. GCC Pharmacovigilance Market
        1. GCC Market Size and Forecast, 2022-2033 (USD Million)
          1. Market Size and Forecast by Type, 2022-2033 (USD Million)
          2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
          3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
          4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
          5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
          6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
        2. South Africa Pharmacovigilance Market
          1. South Africa Market Size and Forecast, 2022-2033 (USD Million)
            1. Market Size and Forecast by Type, 2022-2033 (USD Million)
            2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
            3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
            4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
            5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
            6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
          2. Rest of MEA Pharmacovigilance Market
            1. Rest of MEA Market Size and Forecast, 2022-2033 (USD Million)
              1. Market Size and Forecast by Type, 2022-2033 (USD Million)
              2. Market Size and Forecast by Service Provider, 2022-2033 (USD Million)
              3. Market Size and Forecast by Product Life Cycle, 2022-2033 (USD Million)
              4. Market Size and Forecast byTherapeutic Area, 2022-2033 (USD Million)
              5. Market Size and Forecast byProcess Flow, 2022-2033 (USD Million)
              6. Market Size and Forecast byEnd Use, 2022-2033 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2021 & 2029
    2. Major Recent Developments
  2. Company Profiles

10.1.  Accenture (Ireland)

  1. Company Snapshot
  2. Company Overview
  3. Financials
  4. Product Benchmarking
  5. Recent Developments
  1. ArisGlobal (US)
    1. Company Snapshot
    2. Company Overview
    3. Financials
    4. Product Benchmarking
    5. Recent Developments
  2. Capgemini (France)
    1. Company Snapshot
    2. Company Overview
    3. Financials
    4. Product Benchmarking
    5. Recent Developments
  3. Cognizant (US)
    1. Company Snapshot
    2. Company Overview
    3. Financials
    4. Product Benchmarking
    5. Recent Developments
  4. FMD K&L (US)
    1. Company Snapshot
    2. Company Overview
    3. Financials
    4. Product Benchmarking
    5. Recent Developments
  5. IBM Corporation (US)
    1. Company Snapshot
    2. Company Overview
    3. Financials
    4. Product Benchmarking
    5. Recent Developments
  6. ICON plc. (Ireland)
    1. Company Snapshot
    2. Company Overview
    3. Financials
    4. Product Benchmarking
    5. Recent Developments
  7. IQVIA (US)
    1. Company Snapshot
    2. Company Overview
    3. Financials
    4. Product Benchmarking
    5. Recent Developments
  8. ITClinical (Portugal)
    1. Company Snapshot
    2. Company Overview
    3. Financials
    4. Product Benchmarking
    5. Recent Developments
  9. Laboratory Corporation of America Holdings (US)
    1. Company Snapshot
    2. Company Overview
    3. Financials
    4. Product Benchmarking
    5. Recent Developments
  10. Linical Accelovance (US)
    1. Company Snapshot
    2. Company Overview
    3. Financials
    4. Product Benchmarking
    5. Recent Developments
  11. PAREXEL International Corporation (US)
    1. Company Snapshot
    2. Company Overview
    3. Financials
    4. Product Benchmarking
    5. Recent Developments
  12. TAKE Solutions Ltd. (India)
    1. Company Snapshot
    2. Company Overview
    3. Financials
    4. Product Benchmarking
    5. Recent Developments
  13. Wipro Ltd. (India)
    1. Company Snapshot
    2. Company Overview
    3. Financials
    4. Product Benchmarking
    5. Recent Developments
  14. Company 15
    1. Company Snapshot
    2. Company Overview
    3. Financials
    4. Product Benchmarking
    5. Recent Developments
  15. Others Prominent Players
  1. Conclusion & Recommendations

Leave a comment

Your email address will not be published. Required fields are marked *

Select License Type

5 reasons to choose Quintana Research Reports

Our top-quality, real-time, accurate, and data-driven research aims at empowering the clients with actionable insights.

We deliver timely data-driven insights to help clients make informed decisions and achieve growth and success.

Our team of experts is available 24*7 to offer incisive analysis of the market for clients.

We offer comprehensive and bespoke marketing research as per clients’ requirements.

Our cost-effective and rapid research helps clients gain competitive intelligence, and uncover potential opportunities & threats.